SCIENTURE HOLDINGS, INC. Increase (Decrease) in Other Receivables
SCIENTURE HOLDINGS, INC. (SCNX) reported Increase (Decrease) in Other Receivables of $80.47 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-05-15
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-06-30 was $175.47K.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for the quarter ending 2025-03-31 was -$95.00K, a 101.22% decline year-over-year.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2025 was $80.47K, a 97.24% decline from fiscal 2024.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2024 was $2.91M, a 1043.11% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2023 was $254.92K, a 70.87% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. increase (decrease) in other receivables for fiscal 2022 was $875.25K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $175.47K derived: sum of 3 quarters · filed 2026-03-30 | $80.47K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $175.47K derived: sum of 2 quarters · filed 2025-11-12 | $80.47K 10-Q · filed 2025-11-12 | -$286.56K derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-06-30 | $175.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $80.47K 10-Q · filed 2025-08-12 | -$286.56K derived: sum of 3 quarters · filed 2026-05-15 | $1.99M derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-03-31 | -$95.00K 10-Q · filed 2026-05-15 | -$462.03K derived: sum of 2 quarters · filed 2026-05-15 | $1.81M derived: sum of 3 quarters · filed 2026-05-15 | -$5.00M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$367.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.91M derived: sum of 2 quarters · filed 2026-03-30 | -$4.90M derived: sum of 3 quarters · filed 2026-03-30 | $2.91M 10-K · filed 2026-03-30 |
| 2024-09-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.54M derived: sum of 2 quarters · filed 2025-11-12 | $3.28M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$6.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.01M 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $7.82M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $254.92K 10-K · filed 2025-03-26 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $875.25K 10-K · filed 2024-04-22 | ||
| 2022-09-30 | $875.25K 10-Q · filed 2024-01-16 | |||
| 2021-12-31 | -$1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$1.08M derived: sum of 2 quarters · filed 2023-03-27 | -$1.08M derived: sum of 3 quarters · filed 2023-03-27 | -$1.09M 10-K · filed 2023-03-27 |
| 2021-09-30 | $1.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.28K derived: sum of 2 quarters · filed 2022-11-07 | -$5.14K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-25 | -$6.42K 10-Q · filed 2022-07-25 | ||
| 2021-03-31 | -$6.42K 10-Q · filed 2021-04-26 | |||
| 2020-12-31 | $1.09M 10-K · filed 2021-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |